Bure Equity Stock price
Compare with Peer Group
Is Bure Equity a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
Bure Equity Stock Analysis
Analyst Opinions
9 Analysts have issued a Bure Equity forecast:
Analyst Opinions
9 Analysts have issued a Bure Equity forecast:
Don't miss a Thing! We will send you all news about Bure Equity directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
Bure Equity ABis an investment company with ownership interests in Nordic companies. The company is headquartered in Stockholm, Stockholm and currently employs 11 full-time employees. The firm specializes in long-term owning, developing, as well as disposing listed and unlisted operating entities. Its holding portfolio comprises eight firms: Cavotec, an engineering group that delivers power transmission, distribution and control technologies to a range of areas; MedCap, which owns and develops companies involved in the Life Science sector; Mycronic, which designs and manufactures laser-based pattern generators that are used in the flexible electronics production; PartnerTech, providing product development, as well as production, logistics and aftermarket services; Vitrolife, a developer and producer of solutions for fertility treatment; XVIVO Perfusion AB, which focuses on organ, tissue and cell preservation in relation with transplantation; Investment AB Bure, which owns and manages leasing of locomotives; and Mercuri International, which offers sales and management training consultancy.
| Head office | Sweden |
| CEO | Mr. Blomquist |
| Employees | 12 |
| Website | www.bure.se |


